Department of Neurology, Cognitive and Behavioral Neurology Unit, School of Medicine, Universidade de São Paulo, SP-Brazil.
Department of Nursing and Nutrition of Universidade de Taubaté, Taubaté-São Paulo Brazil.
PLoS One. 2018 Mar 1;13(3):e0193209. doi: 10.1371/journal.pone.0193209. eCollection 2018.
To analyze costs associated with dementia based on a cross-sectional study in the Brazilian health system.
Direct and indirect costs were estimated by conducting comprehensive interviews on the use of resources in a sample of 156 patients with dementia treated at an outpatient memory clinic of a tertiary hospital. A regression model was used to determine the main determinants of costs associated with dementia.
Global costs of dementia were US$1,012.35; US$1,683.18 and US$1,372.30 per patient/month for mild, moderate and severe stages, respectively. Indirect costs ranged from US$536.62 to US$545.17 according to severity. Dementia costs were influenced by medication, FAST score, and educational level of caregiver.
The study represents an original contribution toward establishing direct and indirect costs of dementia in Brazil. Results indicate significant economic impacts, including projection of annual costs of US$16,548.24 per patient.
通过对巴西卫生系统的横断面研究，分析与痴呆相关的成本。
对一家三级医院的门诊记忆诊所中 156 名痴呆患者的资源使用情况进行全面访谈，以估算直接和间接成本。使用回归模型确定与痴呆相关成本的主要决定因素。
痴呆的总费用为 1012.35 美元；轻度、中度和重度阶段的每位患者每月费用分别为 1683.18 美元和 1372.30 美元。间接成本根据严重程度从 536.62 美元到 545.17 美元不等。痴呆的费用受药物、FAST 评分和照顾者的教育水平影响。
该研究对确定巴西痴呆的直接和间接成本做出了原创性贡献。结果表明存在重大的经济影响，包括每位患者每年 16548.24 美元的费用预测。
